Tandem Diabetes Care, Inc. announced that the Board of Directors appointed David B. Berger to serve as the Company's Executive Vice President, Chief Operating Officer and Assistant Secretary. Mr. Berger previously served as Chief Business Operations and Compliance Officer since November 2020. Previously, Mr. Berger was an attorney at Cooley Godward LLP and Amylin Pharmaceuticals, Inc. Mr. Berger holds a B.A. in Economics from the University of California, Berkeley and a J.D. from Stanford Law School.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.23 USD | -0.15% | +7.51% | +59.67% |
May. 15 | Transcript : Tandem Diabetes Care, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:00 AM | |
May. 03 | Sector Update: Health Care Stocks Mixed in Afternoon Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.67% | 3.06B | |
-6.23% | 181B | |
+2.59% | 114B | |
-2.75% | 68.29B | |
+5.32% | 52.24B | |
+7.61% | 44.3B | |
+5.67% | 42.73B | |
+25.17% | 32.52B | |
+17.81% | 26.02B | |
-2.66% | 25.91B |
- Stock Market
- Equities
- TNDM Stock
- News Tandem Diabetes Care, Inc.
- Tandem Diabetes Care, Inc. Appoints David B. Berger as Executive Vice President, Chief Operating Officer and Assistant Secretary